Leishmania donovani has distinct mannosylphosphoryltransferases for the initiation and elongation phases of lipophosphoglycan repeating unit biosynthesis

Molecular and Biochemical Parasitology

Volumn 94, Issue 1, 1998, Pages 27-40

  Descoteaux, Albert ^a,b   Mengeling, Brenda Jo ^b   Beverley, Stephen M ^c   Turco, Salvatore J ^b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glycoconjugates; Leishmania; Lipophosphoglycan; Mannosylphosphoryltransferases

Indexed keywords

GLYCOCONJUGATE; LIPOPHOSPHOGLYCAN; TRANSFERASE;

ARTICLE; BIOSYNTHESIS; ENZYME ACTIVITY; LEISHMANIA DONOVANI; MUTANT; NONHUMAN; PRIORITY JOURNAL;

EID: 0032128405     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(98)00047-4     Document Type: Article

References (44)

1. [1] Chang K-P, Chaudhuri G. Molecular determinants of Leishmania virulence. Annu Rev Microbiol 1990;44:499-529.
2. [2] Turco SJ, Descoteaux A. The lipophosphoglycan of Leishmania parasites. Annu Rev Microbiol 1992;46:65-94.
3. [3] McConville MJ, Ferguson MAJ. The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem J 1993;294:305-24.
4. [4] Mengeling BJ, Beverley SM, Turco SJ. Designing glycoconjugate biosynthesis for an insidious intent: phosphoglycan assembly in Leishmania parasites. Glycobiology 1997;7:873-80.
5. [5] Ilg T, Stierhof Y-D, Wiese M, McConville MJ, Overath P. Characterization of phosphoglycan-containing secretory products of Leishmania. Parasitology 1994; 108:63-71.
6. [6] Wiese M, Ilg T, Lottspeich F, Overath P. Ser/Thr-rich repetitive motifs as targets for phosphoglycan modifications in Leishmania mexicana secreted acid phosphatase. EMBO J 1995;14:1067-74.
7. [7] Ilg T, Stierhof YD, Craik D, Simpson R, Handman E, Bacic A. Purification and structural characterization of a filamentous, mucin-like proteophosphoglycan secreted by Leishmania parasites. J Biol Chem 1996;271:21583-96.
8. [8] McNeely TB, Tolson DL, Pearson TW, Turco SJ. Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies. Glycobiology 1990;1:63-9.
9. [9] Descoteaux A, Luo Y, Turco SJ, Beverley SM. A specialized pathway affecting virulence glycoconjugates of Leishmania. Science 1995;269:1869-72.
10. [10] McNeely TB, Turco SJ. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani with human monocytes. J Immunol 1990;144:2745-50.
11. [11] Giorgione JR, Turco SJ, Epand RM. Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani. Proc Natl Acad Sci USA 1996;93:11634-9.
12. [12] Frankenburg S, Leibovici V, Mansbach N, Turco SJ, Rosen G. Effect of glycolipids of Leishmania parasites on human monocyte activity: Inhibition by lipophosphoglycan. J Immunol 1990; 145:4284-9.
13. [13] Descoteaux A, Turco SJ, Sacks DL, Matlashewski G. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J Immunol 1991;146:2747-53.
14. [14] Carver MA, Turco SJ. Cell-free biosynthesis of lipophosphoglycan from Leishmania donovani. Characterization of microsomal galactosyltransferase and mannosyltransferase activities. J Biol Chem 1991;266:10974-81.
15. [15] Carver MA, Turco SJ. Biosynthesis of lipophosphoglycan from Leishmania donovani: Characterization of mannosylphosphate transfer in vitro. Arch Biochem Biophys 1992;295:309-17.
16. [16] Greis KD, Turco SJ, Thomas JR, McConville MJ, Homans SW, Ferguson MAJ. Purification and characterization of an extracellular phosphoglycan from Leishmania donovani. J Biol Chem 1992;267:5876-81.
17. [17] King DL, Turco SJ. A ricin agglutinin-resistant clone of Leishmania donovani. Mol Biochem Parasitol 1988;28:285-94.
18. [18] Elhay M, Kelleeher M, Bacic A, McConville MJ, Tolson DL, Pearson TW, Handman E. Lipophosphoglycan expression and virulence in ricin-resistant variants of Leishmania major. Mol Biochem Parasitol 1990;40:255-68.
19. [19] Ryan KA, Garraway LA, Descoteaux A, Turco SJ, Beverley SM. Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania. Proc Natl Acad Sci USA 1993;90:8609-13.
20. [20] Ma D, Russell DG, Beverley SM, Turco SJ. Golgi GDP-mannose uptake requires Leishmania LPG2-A member of a eukaryotic family of putative nucleotide-sugar transporters. J Biol Chem 1997;272:3799-805.
21. [21] Descoteaux A, Garraway LA, Ryan KA, Garrity LK, Turco SJ, Beveley SM. Identification of genes by functional complementation in the protozoan parasite Leishmania. In: Adolph KW, editor. Methods in Molecular Genetics. San Diego: Academic Press, 1994:22-48.
22. [22] Tolson DL, Turco SJ, Beecroft RP, Pearson TW. Immunochemical and cell surface arrangement of the Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol Biochem Parasitol 1989;35:109-18.
23. [23] Orlandi PA Jr., Turco SJ. Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. J Biol Chem 1987;262:10384-91.
24. [24] McConville MJ, Bacic A. A family of glycoinositol phospholipids from Leishmania major: Isolation, characterization, and antigenicity. J Biol Chem 1989;264:757-66.
25. [25] Volwerk JJ, Wetherwax PB, Evans LM, Kuppe A, Griffith OH. Phosphatidylinositol-specific Phospholipase C from Bacillus cereus: Improved purification, amino acid composition, and amino-terminal sequence. J Cell Biochem 1989;39:315-25.
26. [26] Mengeling BJ, Zilberstein D, Turco SJ. Biosynthesis of Leishmania lipophosphoglycan: solubilization and partial characterization of the initiating mannosylphosphoryl-transferase. Glycobiology 1997;7:847-53.
27. [27] Ilg T, Harbecke D, Wiese M, Overath P. Monoclonal antibodies directed against Leishmania secreted acid phosphatase and lipophosphoglycan - Partial characterization of private and public epitopes. Eur J Biochem 1993;217:603-15.
28. [28] McConville MJ, Blackwell JM. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J Biol Chem 1991;266:15170-9.
29. [29] Huang C, Turco SJ. Defective galactofuranose addition in lipophosphoglycan biosynthesis in a mutant of Leishmania donovani. J Biol Chem 1993;268:24060-6.
30. [30] Gahmberg CG, Hakomori S. External labeling of cell surface galactose and galactosamine in glycolipid and glycoprotein of human erythrocytes. J Biol Chem 1973;248:4311-7.
31. [31] Butcher BA, Turco SJ, Hilty BA, Pimenta PF, Panunzio M, Sacks DL. Deficiency in β 1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania sand fly interaction. J Biol Chem 1996;271:20573-9.
32. [32] McConville MJ, Homans SW. Identification of the defect in lipophosphoglycan biosynthesis in a non-pathogenic strain of Leishmania major. J Biol Chem 1992;267:5855-61.
33. [33] Elhay MJ, McConville MJ, Curtis JM, Bacic A, Handman E. Identification of truncated forms of lipophosphoglycan in mutant cloned lines of Leishmania major that are deficient in mature lipophosphoglycan. Parasitol Res 1993;79:435-88.
34. [34] Opat A, Ng K, Currie G, Handman E, Bacic A. Characterization of lipophosphoglycan from a Ricin-resistant mutant of Leishmania major. Glycobiology 1996;6:387-97.
35. [35] Brown GM, Millar AR, Masterson C, Brimacombe JS, Nikolaev AV, Ferguson MAJ. Synthetic phosphooligosaccharide fragments of lipophosphoglycan as acceptors for Leishmania major α-D-mannosylphosphate transferase. Eur J Biochem 1996;242:410-6.
36. [36] Pimenta PFP, Turco SJ, McConville MJ, Lawyer PG, Perkins PV, Sacks DL. Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut. Science 1992;256:1812-5.
37. [37] Sacks DL, Saraiva EM, Rowton E, Turco SJ, Pimenta PF. The role of the lipophosphoglycan of Leishmania in vector competence. Parasitology 1994;108:55-62.
38. [38] Pimenta PFP, Saraiva EMB, Rowton E, et al. Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan. Proc Natl Acad Sci USA 1994;91:9155-9.
39. [39] Sacks DL, Pimenta PFP, McConville MJ, Schneider P, Turco SJ. Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J Exp Med 1995;181:685-97.
40. [40] Sacks DL. Metacyclogenesis in Leishmania promastigotes. Exp Parasitol 1989;69:100-3.
41. [41] Puentes SM, Sacks DL, Da Silva RP, Joiner KA. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med 1988;167:887-902.
42. [42] Puentes SM, Da Silva RP, Sacks DL, Hammer CH, Joiner KA. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J Immunol 1990;145:4311-6.
43. [43] Desjardins M, Descoteaux A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med 1997;185:2061-8.
44. [44] Miao L, Stafford A, Nil S, Turco SJ, Flanagan TD, Epand RM. Potent inhibition of viral fusion by the lipophosphoglycan of Leishmania donovani. Biochemistry 1995;34:4676-83.